Assignee
SIGMA ALDRICH CO LLC
US·40 granted patents·60 pending applications·295 citations·filing 2008–2023
Top patents by PatentIndex Score
100 records- 0198US10731181B2CRISPR-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Granted Aug 4, 2020·45 cites·17 claims
- 0297US10947517B2CRISPR/Cas fusion proteins and systemsSIGMA ALDRICH CO LLC·Filed 2020·Granted Mar 16, 2021·9 cites·8 claims
- 0397US10745716B2CRISPR-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Granted Aug 18, 2020·29 cites·22 claims
- 0497US10266851B2Using programmable DNA binding proteins to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2017·Granted Apr 23, 2019·97 cites·18 claims
- 0595US9175023B2Molybdenum allyl complexes and use thereof in thin film depositionSIGMA ALDRICH CO LLC·Filed 2013·Granted Nov 3, 2015·22 cites·7 claims
- 0691US10604752B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2018·Granted Mar 31, 2020·6 cites·22 claims
- 0790US8039062B2Methods of atomic layer deposition using hafnium and zirconium-based precursorsSIGMA ALDRICH CO LLC·Filed 2008·Granted Oct 18, 2011·21 cites·25 claims
- 0888USD962259SDisplay screen or portion thereof with graphical user interfaceSIGMA ALDRICH CO LLC·Filed 2020·Granted Aug 30, 2022·14 cites·1 claims
- 0988USD962282SDisplay screen or portion thereof with graphical user interfaceSIGMA ALDRICH CO LLC·Filed 2020·Granted Aug 30, 2022·15 cites·1 claims
- 1084US10767193B2Engineered CAS9 systems for eukaryotic genome modificationSIGMA ALDRICH CO LLC·Filed 2019·Granted Sep 8, 2020·3 cites·26 claims
- 1183USD980235SDisplay screen or portion thereof with graphical user interfaceSIGMA ALDRICH CO LLC·Filed 2020·Granted Mar 7, 2023·10 cites·1 claims
- 1283US9168507B2Methods for quantitating water using ionic liquid saltsSIGMA ALDRICH CO LLC·Filed 2012·Granted Oct 27, 2015·3 cites·9 claims
- 1381US12275952B2Using programmable DNA binding proteins to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2019·Granted Apr 15, 2025·1 cites·12 claims
- 1481US12065642B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Aug 20, 2024·1 cites·20 claims
- 1581US2024279713A1Degenerate oligonucleotides and their usesSIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 1679USD970517SDisplay screen or portion thereof with graphical user interfaceSIGMA ALDRICH CO LLC·Filed 2020·Granted Nov 22, 2022·8 cites·1 claims
- 1779US2021388396A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 1879US2023287377A1Crispr/cas fusion proteins and systemsSIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 1978US2024067820A1Poloxamer compositions and methods of making and using sameSIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 2076US2024068020A1Methods for next generation genome walking and related compositions and kitsSIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 2176US2020140897A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 2275US2021207173A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 2375US2021079427A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 2474US2021207165A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 2573US11965184B2CRISPR/Cas fusion proteins and systemsSIGMA ALDRICH CO LLC·Filed 2021·Granted Apr 23, 2024·0 cites·10 claims
- 2673US2020002722A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 2772US2021324449A1Degenerate oligonucleotides and their usesSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 2871US10253356B2Visualizing modified nucleotides and nucleic acid interactions in single cellsSIGMA ALDRICH CO LLC·Filed 2015·Granted Apr 9, 2019·1 cites·14 claims
- 2971US10131902B2Micro RNA isolation from biological fluidSIGMA ALDRICH CO LLC·Filed 2014·Granted Nov 20, 2018·1 cites·15 claims
- 3071US2026085327A1Metabolic selection via the serine biosynthesis pathwaySIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 3171US2026098081A1Metabolic selection via the glycine-formate biosynthesis pathwaySIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 3270US10155783B2Manganese complexes and use thereof for preparing thin filmsSIGMA ALDRICH CO LLC·Filed 2014·Granted Dec 18, 2018·1 cites·19 claims
- 3369US11795501B2Methods for next generation genome walking and related compositions and kitsSIGMA ALDRICH CO LLC·Filed 2021·Granted Oct 24, 2023·0 cites·10 claims
- 3469US10570378B2Targeted histone acetylationSIGMA ALDRICH CO LLC·Filed 2013·Granted Feb 25, 2020·2 cites·4 claims
- 3569US2015072899A1Degenerate oligonucleotides and their usesSIGMA ALDRICH CO LLC·Filed 2014·Application pending·0 cites
- 3669US2019300933A1Degenerate oligonucleotides and their usesSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 3769US2024009651A1Pre-coatings for biocompatible solid phase microextraction devicesSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 3868US12084675B2Using programmable DNA binding proteins to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2019·Granted Sep 10, 2024·0 cites·11 claims
- 3967US11891510B2Poloxamer compositions and methods of making and using sameSIGMA ALDRICH CO LLC·Filed 2018·Granted Feb 6, 2024·0 cites·10 claims
- 4067US2020248236A1Degenerate oligonucleotides and their usesSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 4167US2017191082A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2017·Application pending·0 cites
- 4267US2026028611A1Metabolic selection via asparagine biosynthesis pathwaySIGMA ALDRICH CO LLC·Filed 2023·Application pending·0 cites
- 4367US2023374490A1Stable targeted integrationSIGMA ALDRICH CO LLC·Filed 2022·Application pending·0 cites
- 4466US12221606B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Feb 11, 2025·0 cites·13 claims
- 4566US2018135073A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2017·Application pending·0 cites
- 4665US10377990B2Viral resistant cells and uses thereofSIGMA ALDRICH CO LLC·Filed 2015·Granted Aug 13, 2019·1 cites·11 claims
- 4764US10711296B2Directional amplification of RNASIGMA ALDRICH CO LLC·Filed 2016·Granted Jul 14, 2020·1 cites·12 claims
- 4864US2025066816A1Electroporation enhancers for crispr-cas systemsSIGMA ALDRICH CO LLC·Filed 2022·Application pending·0 cites
- 4963US2016017366A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2013·Application pending·0 cites
- 5062US2018134759A1Methods for generating endogenously tagged proteinsSIGMA ALDRICH CO LLC·Filed 2017·Application pending·0 cites
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SIGMA ALDRICH CO LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →